Portal Therapeutics, Inc.
Clinical trials sponsored by Portal Therapeutics, Inc., explained in plain language.
-
Can a daily pill douse the Sun's pain for people with EPP?
Symptom relief CompletedThis phase 2a trial tests whether an experimental oral drug called PORT-77 can lower levels of protoporphyrin IX (PPIX) in the blood of adults with erythropoietic protoporphyria (EPP). People with EPP experience severe pain and skin reactions after even brief sun exposure. The st…
Phase: PHASE2 • Sponsor: Portal Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New drug PORT-77 tested in humans for first time
Knowledge-focused CompletedThis early-stage trial tested the safety of a new drug called PORT-77 in 156 healthy adults. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moves through the body. The goal was to gather initial safety information, not …
Phase: PHASE1 • Sponsor: Portal Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC